Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Takacsy

<< Previous

Bullboard Posts

Next >>

Comment by retiredcfon Jun 26, 2017 3:46pm

197 Views

Post# 26406636

RE:Takacsy

2017-06-26 BUY Stephen Takacsy, B. Eng, MBA

They had very good results last quarter, but it is still a ‘show me’ story to a lot of people. There are big investors accumulating in the name. If management delivers on promises the stock price should go a lot higher.

Login to show your approval Login to show your disapproval / Be the first to comment

Price:

$1.11

Subject:

CANADIAN

Bias:

SELECTIVE

Owned:

Yes

<< Previous

Bullboard Posts

Next >>